Physician profile
Carey A Patrick
NPI 1104824242
$3,071.18
in general payments reported to CMS, 2019-2025
17 companies · $714 in 2025
The $714 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $141 · 2021: $424 · 2022: $486 · 2023: $170 · 2024: $497 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,132.57 | 2019-2025 | Total30, Precision7 |
| Biotissue Holdings INC. | $285.27 | 2023-2025 | |
| Coopervision INC. | $265.73 | 2021-2025 | Misight Contact Lens, Paragon Crt, Synergeyes Contact Lens |
| Bausch & Lomb Americas INC. | $215.67 | 2022-2025 | Infuse |
| Sun Pharmaceutical Industries INC. | $159.98 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $145.24 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $135.14 | 2019-2023 | Axert |
| Shire North American Group INC | $129.45 | 2019 | |
| Genzyme Corporation | $121.35 | 2019 | |
| Allergan, INC. | $105.90 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $96.92 | 2022 | |
| Kala Pharmaceuticals, INC. | $89.55 | 2021 | |
| Dompe US, INC. | $70.38 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $59.07 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.09 | 2019-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $23.23 | 2024 | Xdemvy |
| Optos, INC. | $9.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carey Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.